Tonix Pharmaceuticals Holdings Corp. Prices $70M Common Stock Offering Priced At-The-Market Under Nasdaq Rules

Frank Burrell
Scientific Storytelling

Brenda Snow
Authentic Patient Voice

David Linetsky
Point-of-Care Marketing

Paul Theisen
Patient Acquisition

Liz Kane
Impactful Strategy

Matthew Durham
Omnidynamic Marketing

Joey Cohen
Medication Adherence

Pat Purcell
Meeting Engagement

Daniel Sontupe
Market Access

Stacey Gandler
Brand Nourishment

Amy Giles
Increasing Engagement

Suma Ramadas, PhD
Medical Affairs

Matt Turner
Patient Affordability

Bud Bilanich
Success Coach